Previous close | 1.0100 |
Open | 1.0000 |
Bid | 0.8136 x 200 |
Ask | 1.3500 x 200 |
Day's range | 1.0000 - 1.1800 |
52-week range | 0.9800 - 3.3600 |
Volume | |
Avg. volume | 81,040 |
Market cap | 97.432M |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.4900 |
Earnings date | 13 Jun 2024 - 17 Jun 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
111, Inc. (NASDAQ:YI) Q4 2023 Earnings Call Transcript March 21, 2024 111, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, everyone and thank you for joining 111’s Conference Call today. On the call today from the company are […]
111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.
111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2023 ended December 31, 2023, before the U.S. market opens on Thursday, March 21, 2024.